Medical Education

Merck rolls out MedEd website in India

The website is a joint effort between Merck and The Lancet.

OPDP expands "Bad Ad" with CME

OPDP expands "Bad Ad" with CME

By

The agency made good on a pledge to expand Bad Ad with a web-based CME course and case studies representing common problems.

CME compliance trends up among some outfits

By

Some providers of CME are getting better at complying with accreditation criteria, data show, yet many are still struggling to meet a stricter set of requirements.

CME income rises, despite steep pharma cuts

By

Pharma's med-ed cut was its fifth in a row. But other income surged, filling the void as the funding picture for CME continued to even out.

Industry pushing for further clarity on Sunshine Act

Industry pushing for further clarity on Sunshine Act

By

With a clear buffet exemption in-hand, the agency's position with respect to CME meals seems pretty clear. Industry is pushing for more clarity around the treatment of accrediting bodies.

Study says CME leads to million-dollar savings

By

The estimated cost savings for only 10% of participants changing their practice is somewhere in the million-dollar range, according to a study.

BI, Lilly go simple in new SGLT med-ed effort

BI, Lilly go simple in new SGLT med-ed effort

By

Boehringer Ingelheim and Eli Lilly rolled out a pre-launch SGLT campaign that breaks ranks with branding for J&J's SGLT2 inhibitor Invokana.

Navidea deploying MSLs in launch of new diagnostic agent

Navidea deploying MSLs in launch of new diagnostic agent

By

Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.

ProPublica's Charles Ornstein on life beyond Sunshine

ProPublica's Charles Ornstein on life beyond Sunshine

By

What will become of Dollars for Docs after the Sunshine provisions go into effect? We asked Charles Ornstein, who told us what's next for the project.

Gift study shows med students still being comped

By

Gift bans or no, students still connect with drug companies, a study has found.

Pri-Med in deal to buy EHR firm

By

The med-ed company is buying Amazing Charts, a tie-up the firms say will enable them to deliver customized education to physicians and then assess the patient-level impact.

Most docs don't know about FDA's opioid safety plan: survey

By

Only 35% of physicians are aware of the FDA's class-wide safety plan for certain opioids, a survey showed, suggesting an awareness challenge as the plan gets under way.

Latest 'edu-game' taps into internists' competitive side

Latest 'edu-game' taps into internists' competitive side

By

A new online medical contest is progressing from the diagnosis of minor ailments to cancer screening.

Allergan scrubs some doc-payment data, spares med-ed grants

By

Allergan removed records from its website that had detailed payments made to doctors from the middle of 2010 through first-half 2011.

Video reflects struggle to keep bias out of CME

Video reflects struggle to keep bias out of CME

By

Those who produce and fund certified medical education acknowledge that conflict of interest is one issue that seems to constantly crop up. But while conflict is inevitable, bias doesn't have to be, they insist in a new video.

Pfizer to hand some med-ed grant decisions to external advisors

By

Pfizer is changing the way it funds medical education to make smarter use of a shrinking pool of funds and to enhance the impact of activities it supports.

Stanford research center could elevate CME

By

It probably won't have the same ability to tap industry for support, but a new med-ed center at Stanford has some other interesting parallels with the school's CME program.

Company news: Lighthouse Learning and Shire

The ACCME awarded provisional two-year accreditation to Lighthouse Learning, the educational content provider which develops and sells CME curricula without accepting commercial funding.

ACCME punts on proposed logo ban

By

Corporate logos may still appear in CME commercial support disclosures, ACCME said, after a majority of respondents expressed disapproval of its proposal to ban them.

Doctors chip in more for CME, drugmakers less: report

Doctors chip in more for CME, drugmakers less: report

By

The drug industry's backing of certified CME fell for a third straight year, as registration fees and other income surged, just-released data from ACCME show.

Recent Pfizer CME grants take non-clinical approach

By

In a sign of industry's ongoing desire to broaden its CME funding outlook, a couple of recently supported educational programs by Pfizer aim to foster practice-based improvement as they seek to advance the science of CME.

Lilly becomes latest pharma to disclose non-cash transfers

Lilly becomes latest pharma to disclose non-cash transfers

By

Eli Lilly reported paying $48.1 million to 45,440 physicians and/or 1,827 healthcare organizations during the first quarter, most of it for research and educational programs.

Florida harasses dead doc for off-label months after suicide

Florida harasses dead doc for off-label months after suicide

By

The Florida Department of Health is seeking to sanction a doctor who committed suicide in February, distraught over getting swept up in an off-label promotion sting.

On fifth try, AMA ethics proposal becomes CME policy

On fifth try, AMA ethics proposal becomes CME policy

By

A new report passed by AMA delegates draws ethical boundaries around the use of industry funding for medical education, stopping well short of the all-out ban seen in some previous versions.

ACC nixes current model of CME satellite symposia

By

The American College of Cardiology (ACC) is eliminating its traditional model for CME-certified satellite symposia at the Annual Scientific Session.

GSK paid $57 mil. to doctors for speaking and advising in '10

By

GlaxoSmithKline said Thursday that it paid more than 5,000 US healthcare professionals a total of $56.8 million last year for promotional talks or serving on advisory boards.

Company news: J&J, Roche, Diversified Agency Services (DAS)

Johnson & Johnson reported third-quarter sales of $15 billion, a 0.7% decrease vs. the year-ago quarter, as weaker consumer-product sales weighed on revenue.

Has commercial support for CME bottomed out?

By

Industry support for continuing medical education (CME) has been waning the last two years, but some say the bottom may be in sight.

In stepping up COI rules, Yale takes 'rational' approach to industry

In stepping up COI rules, Yale takes 'rational' approach to industry

By

Yale School of Medicine, which created conflict-of-interest guidelines years ago, has made them binding for physicians in its faculty practice.

Industry support of CME down 17%

By

Total commercial support of accredited CME fell 17% to $856 million in 2009, according to ACCME's annual report—marking its second straight year of double-digit declines on a percentage basis.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters